| Revenue | |
| Research and development | 64K |
| General and administrative | 3.04M |
| Total operating expenses | 3.1M |
| Interest and other income | -12K |
| Interest expense | |
| Adjustment to fair value of common stock warrant liability | 4K |
| Loss on settlement of debt | |
| Operating loss before tax provision (benefit) | -3.09M |
| Tax provision (benefit) | 3K |
| Net loss | |
| Charge for accretion of beneficial conversion rights | |
| Deemed dividend - warrants | |
| Net loss applicable to common stockholders | |
| Net loss per share — basic and diluted | -0.05 |
| Weighted average shares outstanding - basic and diluted (in shares) | |